Tokyo, Feb. 10 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000060628) titled 'Effects of Transcutaneous Auricular Vagus Nerve Stimulation on SEP and PPI' on Feb. 9.
Study Type:
Interventional
Study Design:
Basic Design - Parallel
Randomization - Randomized
Blinding - Single blind -participants are blinded
Control - Placebo
Primary Sponsor:
Institute - Niigata University of Health and Welfare
Condition:
Condition - Healthy adults
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - The purpose of this study is to clarify the effects of taVNS intervention with a modified stimulation frequency of 100Hz on the neural excitation suppression function (SEP, PPI) in athletes with chronic pain and healthy athletes. By examining the impact of different stimulation conditions on central nervous system suppression mechanisms, we aim to obtain fundamental insights for developing more effective taVNS stimulation conditions.
Basic objectives2 - Efficacy
Intervention:
Interventions/Control_1 - Transcutaneous Vagus Nerve Stimulation,Elctroencephalogram
Interventions/Control_2 - sham Stimulation
Eligibility:
Age-lower limit - 18
years-old
=
Gender - Male
Key inclusion criteria - healthy adult
Pain that has persisted for more than three months
Key exclusion criteria - Skin disorders, neurological disorders,
Target Size - 40
Recruitment Status:
Recruitment status - Preinitiation
Date of protocol fixation - 2026 Year 02 Month 09 Day
Anticipated trial start date - 2026 Year 02 Month 09 Day
Last follow-up date - 2026 Year 10 Month 01 Day
To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000069344
Disclaimer: Curated by HT Syndication.
